Epstein-Barr Virus by Qualitative PCR
Also known as: EBVPCR
Use
This test is designed to detect Epstein-Barr Virus (EBV) in individuals suspected of having EBV-related disease. It is not suitable for diagnosing infectious mononucleosis, which is often caused by EBV. The test uses a qualitative PCR method to determine the presence of EBV DNA in a variety of specimens, including bone marrow aspirate, cerebrospinal fluid (CSF), tissue, bronchoalveolar lavage (BAL), and bronchial wash. It aids in the clinical evaluation of patients who are suspected to have latent or active EBV infections related to different diseases.
Special Instructions
It is important to note that if plasma is being submitted as a specimen, the Epstein-Barr Virus by Quantitative NAAT, Plasma test should be ordered instead. The test is performed from Sunday to Saturday, and results are typically reported within 1 to 4 days.
Limitations
The test is not FDA approved and is performed in a CLIA certified laboratory. A negative result does not rule out the presence of PCR inhibitors or assay specific nucleic acids in concentrations below the level of detection by the assay. The test should not be used as an initial diagnostic tool for EBV infections such as infectious mononucleosis.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 31208-2
- 5005-4
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
1 mL
Minimum Volume
0.5 mL
Container
sterile container
Collection Instructions
Transfer bone marrow to a sterile container.
Storage Instructions
Freeze immediately.
Causes for Rejection
Heparinized specimens, tissues in optimal cutting temperature compound.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 week |
| Frozen | 1 year |